Evaxion A (EVAX) Total Liabilities (2019 - 2026)
Evaxion A (EVAX) reported Total Liabilities of $10.4 million for Q1 2026, down 29.95% on a YoY basis from $14.9 million in Q1 2025, and down 8.22% quarter-over-quarter from $11.4 million in Q4 2025.
Evaxion A (EVAX) Total Liabilities (2019 - 2026) Analysis & Trends
Evaxion A has reported Total Liabilities for 8 years, with the latest figure at $10.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 29.95% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (down 29.95% YoY), and the FY2025 full-year result was $11.4 million, down 19.58% from the prior year.
- Total Liabilities for Q1 2026 stood at $10.4 million, down from $11.4 million in the prior quarter.
- The five-year high for Total Liabilities was $16.2 million in Q2 2025, with the low at $20050.0 in Q1 2024.
- Historically, Total Liabilities has averaged $11.3 million across 5 years, with a median of $13.9 million in 2022.
- Annual changes were most pronounced in 2024 — Total Liabilities sank 99.86% — and 2025, when it jumped 74194.26%.
- Evaxion A's Total Liabilities stood at $573000.0 in 2022, then plunged by 66.84% to $190000.0 in 2023, then surged by 7340.53% to $14.1 million in 2024, then retreated by 19.58% to $11.4 million in 2025, then dropped by 8.22% to $10.4 million in 2026.
- The last three Total Liabilities figures came in at $10.4 million (Q1 2026), $11.4 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 9.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.44 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 16.22 Mn |
| Mar 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Jun 30, 2024 | 13.98 Mn |
| Mar 31, 2024 | 20,050.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | 14.68 Mn |
| Jun 30, 2023 | 14.22 Mn |
| Mar 31, 2023 | 13.91 Mn |
| Dec 31, 2022 | 573,000.00 |
| Sep 30, 2022 | 13.90 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 7.73 Mn |
| Sep 30, 2021 | 7.47 Mn |
| Jun 30, 2021 | 5.83 Mn |
| Mar 31, 2021 | 7.12 Mn |